Edition:
India

Bliss GVS Pharma Ltd (BLIS.NS)

BLIS.NS on National Stock Exchange of India

137.05INR
3:56pm IST
Change (% chg)

Rs0.35 (+0.26%)
Prev Close
Rs136.70
Open
Rs137.35
Day's High
Rs138.35
Day's Low
Rs135.20
Volume
145,308
Avg. Vol
380,201
52-wk High
Rs183.70
52-wk Low
Rs73.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2020 Sep 2,101.24 3.000
Jun 2,115.32 3.280
FY 2019 Mar '19 2,440.51 1.756
Dec 2,204.35 2.505
Sep 2,284.30 4.019
Jun 2,053.33 3.720
FY 2018 Mar '18 1,671.00 -1.388
Dec 1,959.22 2.100
Sep 2,265.50 4.930
Jun 2,255.67 3.580
FY 2017 Mar '17 2,583.81 3.211
Dec 2,338.66 2.020
Sep 1,690.07 2.460
Jun 1,410.97 2.670
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Mar-19 1 8,803.51 8,803.51 8,803.51 --
Year Ending Mar-20 1 10,060.40 10,060.40 10,060.40 --
Year Ending Mar-21 1 11,468.80 11,468.80 11,468.80 --
Earnings (per share)
Year Ending Mar-19 1 14.06 14.06 14.06 --
Year Ending Mar-20 1 14.00 14.00 14.00 --
Year Ending Mar-21 1 15.92 15.92 15.92 --
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 15.94 29.88 32.66
P/E High - Last 5 Yrs. 22.16 42.96 47.30
P/E Low - Last 5 Yrs. 4.74 23.36 23.87
Beta 0.61 0.89 0.89
Price to Sales (TTM) 1.83 6.27 7.91
Price to Book (MRQ) -- 5.26 5.38
Price to Tangible Book (MRQ) -- 5.94 6.72
Price to Cash Flow (TTM) 11.00 23.50 24.35
% Owned Institutions -- 0.76 1.46

Dividends

  Company industry sector
Dividend Yield 0.38 1.42 1.35
Dividend Yield - 5 Year Avg 0.60 1.45 1.38
Dividend 5 Year Growth Rate -4.36 3.90 4.54
Payout Ratio(TTM) 0.00 42.57 40.22

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 59.87 5.12 12.22
Sales (TTM) vs TTM 1 Yr. Ago 49.24 6.49 7.74
Sales - 5 Yr. Growth Rate 24.53 10.58 10.87
EPS (MRQ) vs Qtr. 1 Yr. Ago 34.08 40.58 42.97
EPS (TTM) vs TTM 1 Yr. Ago 12.49 -- --
EPS - 5 Yr. Growth Rate 10.26 9.78 10.30
Capital Spending - 5 Yr. Growth Rate 42.77 15.43 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.20
Current Ratio (MRQ) -- 2.93 3.03
LT Debt to Equity (MRQ) -- 7.97 10.23
Total Debt to Equity (MRQ) -- 11.67 14.59
Interest Coverage (TTM) 8.35 33.53 29.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 54.27 51.83 52.20
Gross Margin - 5 Yr. Avg. 52.35 49.68 50.41
EBITD Margin (TTM) 24.67 -- --
EBITD - 5 Yr. Avg 25.91 17.37 13.13
Operating Margin (TTM) 22.23 13.65 6.78
Operating Margin - 5 Yr. Avg. 23.32 13.92 8.93
Pre-Tax Margin (TTM) 22.00 12.27 5.97
Pre-Tax Margin - 5 Yr. Avg. 24.19 14.32 9.22
Net Profit Margin (TTM) 14.21 9.05 2.60
Net Profit Margin - 5 Yr. Avg. 15.17 10.76 5.59
Effective Tax Rate (TTM) 35.41 22.44 22.41
Effective Tax Rate - 5 Yr. Avg. 37.28 22.49 22.75

Efficiency

  Company industry sector
Revenue/Employee (TTM) 19,891,340 992,278,894 886,635,457
Net Income/Employee (TTM) 2,826,917 113,938,124 101,769,932
Receivable Turnover (TTM) -- 5.95 5.96
Inventory Turnover (TTM) -- 2.62 3.36
Asset Turnover (TTM) -- 0.97 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.50 11.12
Return on Assets - 5 Yr. Avg. 11.73 12.95 12.33
Return on Investment (TTM) -- 14.88 14.48
Return on Investment - 5 Yr. Avg. 18.93 16.85 16.02
Return on Equity (TTM) -- 16.01 15.78
Return on Equity - 5 Yr. Avg. 19.90 17.65 17.01
  1 Year 3 Year 5 Year
Sales % 46.23 32.39 24.53
EPS (TTM) % 3.79 27.82 10.26
Dividend % 20.00 6.27 -4.36
Note: Units in Millions of US Dollars

Performance for Bliss GVS Pharma Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -4.15 -4.53 92 24
13 Week 4.10 2.62 99 43
26 Week -5.92 -12.16 99 41
52 Week 11.05 -1.89 99 11
YTD 0.96 -15.50 99 38
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.72%
# of Holders: 8
Total Shares Held: 7,966,220
3 Mo. Net Change: -320,805
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 1
# Reduced Positions: 2
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.